Cost-effectiveness of a smoking cessation program after myocardial infarction

Abstract

Over a wide range of estimates of costs and effectiveness, a nurse-managed smoking cessation program after acute myocardial infarction is an extremely cost-effective intervention. This program is more cost-effective than beta-adrenergic antagonist therapy after myocardial infarction.

A brief smoking cessation intervention for adults in hospital was cost effective

“…1 The analysis by Meenan et al supports and extends these results. The lower cost effectiveness ratios associated with inpatient counselling programmes compared with outpatient educational programmes 2 support the notion of a "teachable moment" when smokers are more likely to respond to a cessation message.…”

Impact of Smoking Status on Long-Term Mortality in Patients With Acute Myocardial Infarction

“…Furthermore, evidence from Western countries had shown that quitting smoking after AMI has considerable economic benefits. 32 In the present study, 74.2% of patients had quit smoking at 3 months after hospital discharge. Other studies have reported that the smoking cessation rate is 42-71% within 6 months after hospital discharge.…”

Issues in the dissemination of cognitive–behavior therapy

“…The program was shown to be efficacious in a number of controlled trials (39,40) and has been shown to be equally effective when disseminated in a variety of real world settings (41). The intervention is cost-effective (42) and has been recommended as a treatment in evidencebased reviews (43).…”